Literature DB >> 7318305

Pharmacokinetics of metildigoxin and digoxin in geriatric patients with normal and elevated serum creatinine levels.

B Kaufmann, A Olcay, W Schaumann, W Teufel, W Weib.   

Abstract

The pharmacokinetics of digoxin and metildigoxin were investigated in geriatric patients on maintenance treatment. Minimum serum glycoside concentrations were determined on 3 consecutive days, and the elimination rate over a withdrawal period of 4 to 6 days was studied. In patients with serum creatinine levels of less than or equal to 1.3 mg/dl, the oral standard dose D1) of digoxin necessary for a minimum serum concentration of 1.0ng/ml was 1.4 times higher than that of metildigoxin. There was no significant difference in the elimination rate of both glycosides. The pharmacokinetics of metildigoxin were further investigated in patients with elevated serum creatinine levels. The standard dose was best correlated with the creatinine clearance, calculated from the serum creatinine, age, weight and sex of the patients. The apparent volume of distribution of metildigoxin decreased with the drug's total body clearance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318305     DOI: 10.2165/00003088-198106060-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  18 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Dose-independent pharmacokinetics of digoxin in humans.

Authors:  H R Ochs; D J Greenblatt; G Bodem; J S Harmatz
Journal:  Am Heart J       Date:  1978-10       Impact factor: 4.749

Review 3.  A nomogram for digoxin therapy.

Authors:  R W Jelliffe; G Brooker
Journal:  Am J Med       Date:  1974-07       Impact factor: 4.965

4.  [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].

Authors:  E E Ohnhaus; P Spring; L Dettli
Journal:  Dtsch Med Wochenschr       Date:  1974-09-13       Impact factor: 0.628

5.  [Micro-determination of creatinine].

Authors:  H Bartels; M Böhmer
Journal:  Clin Chim Acta       Date:  1971-03       Impact factor: 3.786

Review 6.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

Review 7.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

8.  [Gycoside serum concentrations under maintenance therapy with Lanicor, Card-Lamuran, MF708d, and Lanitop (author's transl)].

Authors:  W Weiss; A Olcay; W Teufel; M Glocke
Journal:  Med Klin       Date:  1975-08-29

9.  Comparison of digoxin and medigoxin in normal subjects.

Authors:  R P Hayward; H Greenwood; J Hamer
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

10.  Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.

Authors:  P H Hinderling; E R Garrett; R C Wester
Journal:  J Pharm Sci       Date:  1977-03       Impact factor: 3.534

View more
  3 in total

Review 1.  Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

2.  Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.

Authors:  Yoshihiro Yamanishi; Masaaki Kotera; Minoru Kanehisa; Susumu Goto
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

3.  Pharmacokinetics of digoxin in pregnancy.

Authors:  A M Luxford; G S Kellaway
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.